tradingkey.logo
tradingkey.logo
Search

Redhill Biopharma Ltd

RDHL
Add to Watchlist
0.635USD
+0.005+0.76%
Close 07-31 16:00ETQuotes delayed by 15 min
3.24MMarket Cap
LossP/E TTM

RDHL Financials

See Redhill Biopharma Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Redhill Biopharma Ltd Earnings Date

Latest Release
Apr 27, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
286.00K
-96.44%
EPS(YoY)
-0.10
98.51%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
Financial Indicators
EPS
----
----
----
----
----
----
----
----
100.06%122.50
--12.50K
---50.10K
---559.30K
---206.10K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
-90.21%1.80M
-72.54%3.60M
-42.01%12.80M
-18.77%17.55M
-14.68%18.35M
-36.31%13.10M
2.84%22.07M
3.18%21.61M
2.89%21.50M
1848.39%20.57M
1249.75%21.46M
1394.86%20.94M
1237.11%20.90M
-39.21%1.06M
17.00%1.59M
-36.49%1.40M
-33.49%1.56M
-28.96%1.74M
-32.08%1.36M
44.85%2.21M
Net Profit
----
----
----
----
----
----
----
----
106.50%761.00K
344.74%50.24M
84.70%-3.73M
-66.93%-35.70M
59.79%-11.71M
10.21%-20.53M
-0.17%-24.37M
-14.75%-21.39M
-81.47%-29.12M
-33.26%-22.86M
-108.12%-24.33M
-89.51%-18.64M
-47.11%-16.05M
-73.83%-17.16M
-52.15%-11.69M
2.46%-9.84M
1.89%-10.91M
0.65%-9.87M
26.21%-7.68M
35.00%-10.08M
Net Margin
----
----
----
----
----
----
----
----
166.38%42.37%
--1395.97%
---29.14%
---203.40%
---63.83%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
8.15%55.12%
--55.21%
--32.82%
--46.15%
--50.97%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
113.97%4.22%
-54.03%1.16%
-61.23%1.97%
----
-61.13%2.53%
----
-93.41%5.09%
----
-88.31%6.52%
--11.89%
--77.23%
--76.87%
--55.75%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
-90.21%1.80M
-72.54%3.60M
-42.01%12.80M
-18.77%17.55M
-14.68%18.35M
-36.31%13.10M
2.84%22.07M
3.18%21.61M
2.89%21.50M
1848.39%20.57M
1249.75%21.46M
1394.86%20.94M
1237.11%20.90M
-39.21%1.06M
17.00%1.59M
-36.49%1.40M
-33.49%1.56M
-28.96%1.74M
-32.08%1.36M
44.85%2.21M
Operating profit
----
----
----
----
----
----
----
----
51.87%-4.41M
274.88%29.08M
15.69%-9.95M
59.14%-7.11M
63.20%-9.16M
8.39%-16.63M
37.60%-11.80M
-20.32%-17.40M
-99.09%-24.89M
-11.94%-18.15M
-60.73%-18.91M
-46.89%-14.46M
-0.97%-12.50M
-76.01%-16.22M
-17.14%-11.76M
-1.11%-9.84M
-29.54%-12.38M
7.82%-9.21M
30.09%-10.04M
30.28%-9.74M
Net Profit
----
----
----
----
----
----
----
----
106.50%761.00K
344.74%50.24M
84.70%-3.73M
-66.93%-35.70M
59.79%-11.71M
10.21%-20.53M
-0.17%-24.37M
-14.75%-21.39M
-81.47%-29.12M
-33.26%-22.86M
-108.12%-24.33M
-89.51%-18.64M
-47.11%-16.05M
-73.83%-17.16M
-52.15%-11.69M
2.46%-9.84M
1.89%-10.91M
0.65%-9.87M
26.21%-7.68M
35.00%-10.08M
Current assets
-45.19%6.53M
-20.05%12.55M
-26.20%11.91M
----
-41.94%15.70M
----
-81.21%16.14M
----
-70.37%27.05M
-35.91%46.52M
-3.65%85.90M
-0.02%83.10M
-7.33%91.27M
-35.58%72.58M
26.47%89.15M
45.94%83.11M
61.13%98.49M
11.51%112.66M
32.47%70.50M
84.88%56.95M
52.92%61.13M
104.16%101.03M
-6.29%53.21M
----
----
----
----
----
Total current liabilities
-13.51%19.22M
4.96%22.29M
11.21%22.22M
----
-24.67%21.23M
----
-89.88%19.98M
----
-83.06%28.19M
-34.46%48.44M
142.36%197.45M
136.99%193.53M
110.19%166.41M
10.91%73.90M
11.24%81.47M
158.01%81.66M
120.69%79.17M
284.58%66.63M
589.85%73.23M
128.02%31.65M
155.28%35.87M
43.32%17.32M
2.26%10.62M
----
----
----
----
----
Total assets
40.47%25.34M
-16.57%18.38M
-21.71%18.04M
----
-37.14%22.02M
----
-85.49%23.05M
----
-79.14%35.04M
-64.78%58.83M
-12.32%158.87M
-15.64%157.19M
-17.53%167.97M
-24.11%167.05M
0.53%181.19M
10.27%186.34M
22.42%203.67M
53.42%220.12M
143.24%180.24M
319.88%168.98M
234.78%166.37M
146.81%143.48M
18.73%74.10M
----
----
----
----
----
Total liabilities
-7.26%21.08M
3.75%22.79M
8.33%22.73M
----
-30.42%21.96M
----
-89.88%20.98M
----
-82.45%31.57M
-67.02%56.83M
20.29%207.27M
16.27%203.22M
3.34%179.91M
3.12%172.29M
3.57%172.31M
24.64%174.79M
32.10%174.09M
67.36%167.08M
1080.23%166.38M
706.23%140.24M
640.73%131.78M
514.02%99.83M
25.59%14.10M
----
----
----
----
----
Total equity
191.14%4.27M
-7332.79%-4.41M
-326.34%-4.68M
----
-98.24%61.00K
----
104.27%2.07M
----
129.07%3.47M
138.22%2.00M
-645.35%-48.40M
-498.54%-46.03M
-140.36%-11.94M
-109.88%-5.24M
-35.99%8.88M
-59.82%11.55M
-14.47%29.58M
21.52%53.04M
-76.89%13.86M
25.80%28.75M
8.41%34.59M
4.23%43.65M
17.22%60.00M
----
----
----
----
----
Net operating income
----
----
----
----
----
----
----
----
36.14%-10.59M
-72.95%-7.19M
83.71%-2.42M
68.32%-6.03M
12.26%-16.58M
66.13%-4.16M
-16.95%-14.86M
-107.45%-19.02M
-25.74%-18.90M
-15.46%-12.27M
8.39%-12.71M
-3.11%-9.17M
-43.78%-15.03M
-41.03%-10.62M
-69.26%-13.87M
-6.24%-8.89M
-24.46%-10.45M
20.67%-7.53M
42.15%-8.19M
20.68%-8.37M
Net investment
----
----
----
----
----
----
----
----
95.71%-7.00K
-100.00%0.00
-100.00%0.00
99.74%-22.00K
95.35%-163.00K
2093.02%8.49M
-55.46%3.50M
-825.81%-8.52M
92.97%-3.50M
-90.33%387.00K
260.36%7.85M
-90.00%1.17M
-1368.88%-49.80M
133.64%4.00M
-825.33%-4.90M
675.67%11.74M
-152.51%-3.39M
125.26%1.71M
107.48%675.00K
-114.65%-2.04M
Net financing
----
----
----
----
----
----
----
----
-99.98%3.00K
197.29%4.81M
-59.02%7.20M
-472.67%-5.72M
943.24%14.92M
-108.43%-4.94M
121.25%17.57M
-108.36%-999.00K
-132.41%-1.77M
-0.72%58.66M
-78.00%7.94M
5903.88%11.96M
2843.22%5.46M
31865.59%59.08M
102.17%36.10M
-100.87%-206.00K
---199.00K
-28.28%-186.00K
-14.70%17.86M
78406.67%23.55M

FAQs

What is the total revenue of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its total revenue reached 286.00K, with a year-on-year change of 8.04M.

What are the current assets of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its current assets were 6.53M, with a year-on-year change of -45.19.

What are the total assets of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its total assets of Redhill Biopharma Ltd were 25.34M, with a year-on-year change of 40.47.

What are the total liabilities of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its total liabilities of Redhill Biopharma Ltd were 21.08M, with a year-on-year change of -7.26.

What is the total equity of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its total equity of Redhill Biopharma Ltd was 4.27M, with a year-on-year change of 191.14.

What is the net operating income of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its net operating income of Redhill Biopharma Ltd was -7.91M, with a year-on-year change of 45.88.

What is the net investment of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its net investment of Redhill Biopharma Ltd was 1.69M, with a year-on-year change of 18888.89.

What is the net financing of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its net financing of Redhill Biopharma Ltd was 7.32M, with a year-on-year change of -13.07.

What is the Earnings Per Share (EPS) of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.10, with a year-on-year change of 98.51.

What is the net income of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its net income was -429.00K, with a year-on-year change of 94.81.

What is the net margin of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its net profit margin was -2825.17, with a year-on-year change of -2648.29.

What is the gross margin of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its gross margin was 100.00, with a year-on-year change of 65.80.

What is the debt-to-asset ratio of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its debt-to-asset ratio was 4.22, with a year-on-year change of 113.97.

What is the Return on Assets (ROA) of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -37.25, with a year-on-year change of 7.45.

What is the operating profit of Redhill Biopharma Ltd?

According to Redhill Biopharma Ltd's FY2025 earnings report, its operating profit was -7.91M, with a year-on-year change of 45.88.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.